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Abstract
Background: With the advent of novel recanalization techniques and emerging devices, percutaneous 
coronary intervention (PCI) has become a promising leading treatment option for patients with chronic 
total occlusions (CTO). The present study aims to evaluate the acute outcomes of PCI in previously 
failed re-attempted vs. first-attempted CTO-lesions.
Methods: Between 2012 and 2019, 619 patients were included and treated with PCI of at least one 
CTO. 253 patients were re-attempted lesions, while 366 were initially attempted lesions.
Results: Re-attempted lesions were more complex, including higher Japanese-CTO (J-CTO) score and 
the need for a retrograde approach. The procedure time and fluoroscopy time were longer in this group. 
Nevertheless, overall success rates were comparable between both groups of patients. In-hospital events 
were rare and without significant differences.
Conclusions: Re-attempted CTO lesions are more complex than first-attempt lesions and are associ-
ated with longer procedural times. However, they can be safely intervened by experienced operators with 
a similar success rate. (Cardiol J)
Key words: re-attempt, chronic total occlusion, coronary artery disease, percutaneous 
coronary intervention 
Introduction
Recanalization of chronic total occlusion (CTO) 
still remains a challenging procedure in interven-
tional cardiology. A CTO of a coronary artery can 
be identified in up to 18% among patients referred 
for coronary angiography [1]. With the advent of 
novel recanalization techniques and emerging de-
vices, percutaneous coronary intervention (PCI) 
has become a promising leading treatment option 
for these patients [2–7].
Previous observational studies have demon-
strated that successful CTO-PCI is associated with 
a better outcome in terms of reduced mortality and 
major adverse cardiac events (MACE) compared 
with CTO-PCI failure [8–11]. Several scores are 
currently used to estimate the procedural com-
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score is still the most widely used [12–14]. J-CTO 
identifies a prior CTO-PCI failure as one of the 
five determinants to estimate the procedural com-
plexity of a CTO-PCI. A considerable number of 
patients with failed CTO-PCI attempt are medically 
managed, instead of re-attempting the PCI [15]. 
The current literature provides only limited data 
about this challenging patient subgroup.
The present study aims to compare the acute 
outcomes of re-attempted CTO-PCI vs. first-
-attempt CTO-PCI.
Methods 
The present study was designed as an obser-
vational retrospective study, including patients un-
dergoing CTO-PCI in an experienced German CTO 
center between 2012 and 2019. The indication for 
CTO-PCI was based on current recommendations 
requiring the presence of clinical symptoms, in-
cluding angina, dyspnea or limited exercise capac-
ity [16–18]. Myocardial viability was proven either 
by evidence of normal wall motion or hypokinesia 
in the CTO territory, assessed by transthoracic 
echocardiography. In the presence of akinesia in 
the CTO-territory, positive functional ischemia/ 
/viability was proven by stress-echocardiography 
or cardiac magnetic resonance imaging (cMRI).
All procedures were performed via bifemo-
ral approach using 7-French guiding catheters. 
Contra-lateral contrast injections were performed 
to determine the length of the CTO lesion and the 
existence and extent of collateral connections in 
the majority of patients. The decision to treat pa-
tients either by antegrade or retrograde CTO-PCI 
techniques was left to the operators’ discretion. To 
prevent thromboembolic complications, heparin 
was intravenously administered during CTO-PCI, 
guided by regular measurements of the activated 
clotting time (> 300 s).
The J-CTO score, including the degree of cal-
cification of the lesion, bending > 45° in the CTO 
segment or at the entry, blunt proximal cap, length 
of occluded segment (> 20 mm) and a previously 
failed recanalization attempt, was calculated for all 
patients. The study was performed in accordance 
with the Declaration of Helsinki.
After CTO-PCI a dual antiplatelet therapy con-
sisting of 100 mg of acetylsalicylic acid once daily 
indefinitely and 75 mg of clopidogrel once daily for 
at least 6 months was administered. Angiographic 
success was defined as a successful recanaliza-
tion of the CTO with a residual stenosis less than 
30% and restoration of thrombolysis in myocardial 
infarction (TIMI)-flow grade 3. 
A composite safety endpoint combining in-
hospital death, vascular complications, cardiac 
tamponade, periprocedural infarction and an acute 
stent thrombosis was evaluated for every patient.
Statistical analysis
Continuous variables are presented as mean 
standard deviation, median (Q1–Q3) or as mini-
mum to maximum range. Categorical variables 
are presented as absolute and relative frequen-
cies. Normality of the variables was tested with 
the Shapiro-Wilk test. Continuous variables were 
compared with the Student t-test for unpaired 
samples, or with the Mann-Whitney U-test if 
a Gaussian distribution could not be assumed. For 
comparison of continuous variables among > two 
categories were performed with non-parametric 
Kruskal-Wallis test. Categorical variables were 
compared using the Fisher exact test. According 
to the exploratory character of the analysis all 
p values were interpreted as descriptive measures 
rather than as definitive inferential measures. 
A p-value of less than 0.05 was considered sta-
tistically significant, p < 0.10 was considered as 
a statistical trend.
Results
A total of 619 patients were included between 
2012 and 2019. 253 (40.9%) patients were re-
attempted lesions that had failed once previously, 
while 366 (59.1%) were initially attempted lesions.
The majority of the patients were male (82.4%) 
and the mean age was 62.0 ± 10.3 years. Male 
patients were younger than women (61.1 ± 10.1 
years vs. 66.3 ± 10.1 years; p < 0.005). 
Table 1 presents the baseline clinical charac-
teristics of the study patients. The major cardio-
vascular risk factors were similar between both 
groups, such as diabetes mellitus, hypertension and 
dyslipidemia. Furthermore, the rates of comorbidi-
ties like peripheral artery disease were comparable 
as well. Patients with a re-attempted lesion were 
less likely to have chronic obstructive pulmonary 
disease (7.1% vs. 11.7%; statistical trend p = 0.074) 
and more often had an ejection fraction of more than 
40% (97.2% vs. 94.0%; statistical trend p = 0.080). 
Interestingly the target vessel in these patients 
was mostly the right coronary artery (RCA; 65.2%), 
followed by the left anterior descending artery 
(LAD; 20.6%) and the left circumflex artery (LCX; 
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14.2%). Patients with an initially attempted lesion 
had a different distribution (RCA: 54.9%, LAD: 
32.5%, LCX: 10.9%; p = 0.003) and more often 
a multivessel coronary artery disease (79.0% vs. 
67.9%; p = 0.005). The success (p = 1.000) and 
complication rates (p = 0.385) were independent 
of the target vessel.
Peri-procedural characteristics are demon-
strated in Table 2. Patients with a re-attempted 
lesion had more often a blunt stump morphology 
(70.0% vs. 58.2%, p = 0.003) and a higher J-CTO 
score (62.5% vs. 18.6%, p ≤ 0.001; Fig. 1). It was 
also determined that examination and fluoroscopy 
time were longer in this group (120 min vs. 90 min, 
p < 0.001 and 37 min vs. 28 min, p < 0.001; Fig. 2) 
and that in this group of patients the retrograde ap-
proach was more frequently used (32.4% vs. 12.0%, 
p < 0.001). Patients with an initially attempted le-
sion were less likely to have an ostial lesion (8.7% 
vs. 14.2%, p = 0.036) and showed rarely an in-stent 
CTO (6.3% vs. 18.2%, p < 0.001). 
The most frequent reason for failure in re-
attempted CTO lesions was the failure of the 
guidewire to cross the lesion. No procedure was 
discontinued due to complications.
Overall success rates were comparable be-
tween the two group of patients (86.9% vs. 83.0%, 
p = 0.204). 
Reverse controlled antegrade and retrograde 
tracking and parallel-wire techniques were more 
frequently used in re-attempted than in first-
attempt lesions (67.1% vs. 41%, p < 0.001 and 
24.4% vs. 8.9%, p < 0.001, respectively).
In-hospital, acute procedural complications 
regarding the composite safety endpoint were rare 
and showed no significant difference (6.0% vs. 
4.0%, p = 0.467). They included mostly vascular 
complications (n = 26) such as a local hematoma 
at the puncture site and could be treated without 
further consequences. No severe complications 
such as peri-procedural death, ST-segment eleva-
tion myocardial infarction occurred (Table 3).
Table 1. Baseline characteristics.
Initial attempt (n = 366) Re-attempt (n = 253) P
Age [years]* 62 (37–86) 61 (33–87) 0.114
Hypertension 81.4% (298) 81.4% (206) 1
Diabetes 27.3% (100) 24.1% (61) 0.402
Male gender 83.6% (306) 80.6% (204) 0.391
Smoking 44.8% (164) 47.8% (121) 0.462
COPD 11.7% (43) 7.1% (18) 0.074
Body mass index* 27.5 (18.0–46.7) 27.4 (17.0–45.0) 0.604
Total cholesterol > 200 mg/dL 21.2% (49) 17.9% (35) 0.464
LDL cholesterol > 100 mg/dL 48.5% (112) 47.7% (93) 0.923
HDL cholesterol > 40 mg/dL 68.0% (157) 67.7% (132) 1
Triglycerides > 150 mg/dL 45.9% (106) 48.2% (94) 0.697
Peripheral artery disease 12.0% (44) 12.3% (31) 1
Family liability for CAD 28.1% (103) 26.1% (66) 0.583
Prior MI 30.9% (113) 37.5% (95) 0.100
Prior CABG 9.6% (35) 9.1% (23) 0.889
Prior PCI 47.3% (238) 43.5% (32) 0.367
Ejection fraction ≥ 40% 94.0% (505) 97.2% (66) 0.080
Multivessel disease 79.0% (289) 67.9% (172) 0.003
CTO location: 0.003
LAD 32.5% (119) 20.6% (52)
LCX 10.9% (40) 14.2% (36)
RCA 54.9% (201) 65.2% (165)
*Median (min–max); CABG — coronary artery bypass grafting; CAD — coronary artery disease; COPD — chronic obstructive pulmonary  
disease; CTO — chronic total occlusion; HDL — high density lipoprotein; LAD — left anterior descending; LDL — low density lipoprotein;  
LCX — left circumflex; MI — myocardial infarction; PCI — percutaneous coronary intervention; RCA — right coronary artery
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Patients without a successful recanalization in 
a second attempt were treated medically in 69%, 
whilst 31% underwent coronary artery bypass 
grafting (CABG).
Discussion
According to available research itis known that 
an incomplete revascularization is accompanied by 
Table 2. Procedural and angiographic characteristics.
Initial attempt (n = 366) Re-attempt (n = 253) P
Complication rate 6.0% (22) 4.0% (11) 0.467
Success rate 86.9% (318) 83.0% (210) 0.204
Calcification 65.6% (240) 77.5% (196) 0.002
Length of lesion [mm]* 30 (10–100) 30 (10–79) 0.240
In-stent CTO 6.3% (23) 18.2% (46) < 0.001
Blunt stump 58.2% (213) 70.0% (177) 0.003
Ostial CTO 8.7% (32) 14.2% (36) 0.036
J-CTO score > 3 18.6% (68) 62.5% (158) < 0.001
Retrograde technique 12.0% (44) 32.4% (82) < 0.001
Stent type: 0.686
DES 99.1% (457) 98.6% (47)
BMS 0.9% (3) 1.4% (3)
Diameter of stent [mm]* 3.0 (2.25–4.0) 3.0 (2.5–-4.0) 0.332
Lenght of stent [mm]* 62 (12–157) 64 (18–170) 0.955
Number of stents* 2 (0–6) 2 (0–6) 0.490
Amount of contrast medium [mL]* 200 (70–750) 200 (80–800) 0.161
Fluoroscopy time [min]* 28 (4–113) 37 (7–104) < 0.001
Examination time [min]* 90 (11–208) 120 (20–300) < 0.001
*Median (min–max), BMS — bare metal stent; CTO — chronic total occlusion; DES — drug eluting stent; J-CTO — Japanese CTO
Figure 1. Various parameters of initial attempted and re-attempted chronic total occlusion percutaneous coronary 
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increased adverse events [19, 20]. Therefore, it 
should be a goal to perform a successful recanaliza-
tion even after a failed CTO-PCI attempt.
In a large meta-analysis with more than 7000 
patients, Joyal et al. [21] demonstrated that suc-
cessful CTO-PCI compared to a failed attempt 
could show a reduction, not only in long-term mor-
tality, but also the need for CABG. Furthermore, 
van der Schaaf et al. [22] showed that the pres-
ence of a non-revascularized CTO increases the 
long-term mortality in a case of acute myocardial 
infarction [21, 22]. As is done nowadays, CTO-PCI 
can be performed in a safe and sufficient way by 
most CTO centers, the present study empha-
sizes several important aspects of CTO-PCI in 
re-attempted cases. 
Firstly, the present study, in contrast to other 
studies, it was shown that recanalization of re-
attempted lesion can be performed with similar 
success and complication rates compared with 
first-attempt lesions [19]. This is the case, even 
though our data suggests a higher complexity in 
re-attempted lesions than in firs-attempt cases, 
as indicated by the higher J-CTO score. The fact 
that all cases in the study were performed by two 
highly-experienced CTO operators, might have 
also played an instrumental role in the excellent 
results reported.
Despite the fact that a re-attempt itself is 
counted as a point of complexity in the J-CTO 
score, it was determined that calcification, tor-
tuosity and blunt stump morphology were sig-
nificantly increased in patients with a re-attempt. 
These findings are in accordance with data from 
Tanabe et al. [19]. But, in that study only about 
300 patients, 59 with a re-attempted lesion, were 
included and the success rate was much lower in 
the patients with re-attempted lesions (69.5%) due 
to the fact that treatment devices failed to cross 
even after successful guidewire crossing. In a large 
Japanese CTO registry, more than 4000 patients 
were included and the technical success rate of 
re-attempt CTO-PCI was lower than that of first 
attempt CTO-PCI, but the mean age of this cohort 
was much older than in our study [23].
Second, re-attempted CTO lesions required 
complex interventional approaches, for instance 
the retrograde approach, with longer fluoroscopic 
and examination times. This finding is congruent 
to a large multicenter registry from 2015 which 
showed that the mean procedure duration was 
significantly longer in the group with prior failed 
CTO-PCI attempts (142 vs. 125 min, p = 0.026), 
as was mean fluoroscopy time (55 vs. 45 min, 
p = 0.015) [24].
As shown by the large EURO CTO Club reg-
istry that the number of retrograde procedures 
has been continually increasing over recent years, 
based on the higher complexity of lesion subsets, 
giving us more technical options to increase the 
success rates in CTO-PCI, despite low rates of 
major complications, and good long-term outcome. 
This has recently been confirmed by the data of 
Tanaka et al. [25, 26]. Wei et al. [27] examined 
2124 patients who received cardiac fluoroscopic 
interventions and found that a chronic skin ulcer 
developed in 0.34%. Since then, there have been 
significant reductions in radiation doses over time 
by introducing new techniques and changes in 
fluoroscopy settings [27–30]. 
Third, re-attempted lesions are often in-stent 
lesions. This is in accordance with a large study by 
Karacsonyi et al. [24] comprising 1213 consecu-
tive patients from 12 centers in the United States 
between 2012 and 2015. Interestingly, in contrast 
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Figure 2. Comparison of initial attempted and re-at-
tempted chronic total occlusion percutaneous coronary 
intervention regarding examination and fluoroscopy 
time.
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to the present study, this cohort the incidence of 
MACE was numerically higher among prior failed 
cases [24]. It should be pointed out that PCI for in-
stent CTO might be associated with higher odds of 
MACE and myocardial infarction compared to PCI 
for de-novo CTO [31]. Finally, the current study 
demonstrated that RCA was the target vessel in 
both groups. Interestingly CTOs located in the 
LAD artery were more often treated in the setting 
of re-attempted PCI. 
Since it is known that especially after a suc-
cessful recanalization of the LAD, ejection fraction 
and clinical outcome may improve [32–34], efforts 
should focus on revascularization of this vessel.
Limitations of the study
The present study is a retrospective analysis 
and all data are collected from a single center. The 
results of this study may have been influenced by 
selection criteria, bias on operator’s experience, 
and varying techniques used by the two operators 
involved. Furthermore, no data about the impact of 
the long-term follow-up in this cohort is reported.
Conclusions
Percutaneous coronary intervention of re-
attempted CTO lesions are as safe as primary CTO 
attempts, with comparable success rates. PCI of 
re-attempted CTO lesions has shown higher ana-
tomical complexity, requiring a more complex ap-
proach, including retrograde techniques and longer 
procedures times, for successful revascularization. 
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